Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

8.95
+0.11001.24%
Post-market: 8.90-0.0500-0.56%19:03 EDT
Volume:350.84K
Turnover:3.11M
Market Cap:761.32M
PE:-16.20
High:8.99
Open:8.81
Low:8.70
Close:8.84
Loading ...
Jan 27, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 27, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2022

Major Issues Report

8-K - Current report
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 02, 2022

Major Issues Report

8-K - Current report
Sep 13, 2021

Major Issues Report

ANAVEX LIFE SCIENCES CORP.
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities